Medifast Q3 Adj. EPS $(0.19) Beats $(0.35) Estimate, Sales $72.048M Beat $71.300M Estimate

Medifast (NYSE:MED) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.35) by 45.71 percent. This is a 9.52 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $72.048 million which beat the analyst consensus estimate of $71.300 million by 1.05 percent. This is a 19.42 percent decrease over sales of $89.409 million the same period last year.